MISSISSAUGA, Ontario, Oct. 26 /PRNewswire-FirstCall/ -- CardioGenics Holdings Inc. has received notification from FINRA that the name and ticker symbol change for the Company on the OTCBB will take place at the beginning of business on Tuesday, October 27, 2009. The new ticker symbol for “CardioGenics Holdings Inc.” on the OTC Bulletin Board will be “CGNH”. In addition to the name and ticker symbol change that is scheduled to take place tomorrow on the OTC Bulletin Board, the CUSIP for the Company’s common stock will also change tomorrow to 14160X 104. For reference of the official change, please visit the following link: http://www.otcbb.com/asp/dailylist_detail.asp?mkt_ctg=OTCBB&d=10/26/2009.
Through its CardioGenics subsidiaries, the Company develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company’s principal offices are located in Mississauga, Ontario, Canada.
CONTACT: The Investor Relations Group, Adam Holdsworth, +1-212-825-3210,
or Media Relations: Mike Graff, +1-212-825-3210